RGMB Enhances the Suppressive Activity of the Monomeric Secreted Form of CTLA-4

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-43068-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Radiotherapy Enhances Responses of Lung Cancer to CTLA-4 Blockade

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

A3.23 Vitamin D Antagonises the Suppressive Effect of Inflammatory Cytokines Upon CTLA-4 Expression and Regulatory Function

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2013English

Ctla-4 (Cd152)

Science-Business eXchange
2010English

The Soluble Isoform of CTLA-4 Correlates With Interferon-Α Activity in Systemic Lupus Erythematosus

Journal of Rheumatology
RheumatologyAllergyImmunology
2019English

Platelet-Derived Growth Factor Agonist Activity of a Secreted Form of the V-Sis Oncogene Product.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Syngeneic Animal Models of Tobacco-Associated Oral Cancer Reveal the Activity of in Situ Anti-Ctla-4

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Inhibition of SRC Activity Enhances the Tumor-Suppressive Effect of the Connexin 32 Gene in Caki-1 Renal Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2006English

CTLA-4 Blockade Enhances the Immune Response Induced by Mycobacterial Infection but Does Not Lead to Increased Protection

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1999English

Evidence for a Functional Monomeric Form of the Bacteriophage T4 Dda Helicase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy